Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20170168Phase 3Completed
A Phase 3 trial of human chorionic gonadotropin in female infertility, anovulation, Oligo-ovulation, sponsored by Livzon Monoclonal Antibody. Started Feb 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20170168.